These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19228265)

  • 1. Are haemophiliacs protected against cancer development? Prospective controlled studies are needed.
    Franchini M; Lippi G
    J Cell Mol Med; 2009 Jun; 13(6):1185. PubMed ID: 19228265
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders.
    Brüggemann LW; Versteeg HH; Niers TM; Reitsma PH; Spek CA
    J Cell Mol Med; 2008 Dec; 12(6B):2622-7. PubMed ID: 18363839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert intravascular clotting.
    Penick GD; Roberts HR; Dejanov II
    Fed Proc; 1965; 24(4):835-9. PubMed ID: 5890296
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic expression of murine hemophilia.
    Muchitsch EM; Turecek PL; Zimmermann K; Pichler L; Auer W; Richter G; Gritsch H; Schwarz HP
    Thromb Haemost; 1999 Oct; 82(4):1371-3. PubMed ID: 10544939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach].
    Moro GF; Campolongo F
    Riv Ital Stomatol; 1983; 52(7-8):589-92. PubMed ID: 6236541
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular genetics of coagulation factor VIII gene and hemophilia A.
    Antonarakis SE
    Thromb Haemost; 1995 Jul; 74(1):322-8. PubMed ID: 8578479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.
    Girard TJ; Lasky NM; Grunz K; Broze GJ
    J Thromb Haemost; 2019 Jan; 17(1):149-156. PubMed ID: 30451376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein.
    Jackson DP
    Trans Am Clin Climatol Assoc; 1971; 82():114-23. PubMed ID: 4934014
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
    Kuang Y; Wang J; Lu X; Lu S; Zhang L; Shen C; Fei J; Wang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):1-6. PubMed ID: 20140858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.
    Daidone V; Galletta E; Bertomoro A; Casonato A
    Blood Transfus; 2018 Jan; 16(1):114-117. PubMed ID: 27893350
    [No Abstract]   [Full Text] [Related]  

  • 12. The factor VIII protein and its function.
    Mazurkiewicz-Pisarek A; Płucienniczak G; Ciach T; Płucienniczak A
    Acta Biochim Pol; 2016; 63(1):11-16. PubMed ID: 26824291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the hereditary coagulation disorders.
    Mason DY; Ingram GI
    Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice.
    Khallou-Laschet J; Caligiuri G; Tupin E; Gaston AT; Poirier B; Groyer E; Urbain D; Maisnier-Patin S; Sarkar R; Kaveri SV; Lacroix-Desmazes S; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):e123-6. PubMed ID: 15920033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of D.D.A.V.P. on the survival of factor VIII in severe haemophiliacs.
    McLellan DS; Knight S; McLellan HG; Wassef M; Aronstam A
    Thromb Res; 1985 Oct; 40(1):113-9. PubMed ID: 3937282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The so-called antithromboplastin (ogen)emias].
    Pelick E; von Knorre G; Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(3):209-13. PubMed ID: 4100724
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effect of moderate intensity aquatic exercise on coagulation factors in haemophiliacs.
    Beltrame LG; Abreu L; Almeida J; Boullosa DA
    Clin Physiol Funct Imaging; 2015 May; 35(3):191-6. PubMed ID: 24720506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screen and analysis of FVIII inhibitors in 167 hemophilia A patients].
    Liu XH; Wang HF; Yang R
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):627-9. PubMed ID: 22338160
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary bleeding disorders as seen at the Kenyatta National Hospital, Nairobi, Kenya.
    Kasili EG; Kariithi MW
    Trop Doct; 1979 Apr; 9(2):76-80. PubMed ID: 314190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.